Columbus McKinnon Reports Revenue Growth of 30% for Third Quarter Fiscal Year 2022
Columbus McKinnon Corporation (Nasdaq: CMCO) reported a solid third quarter for fiscal 2022, achieving a 29.7% year-over-year sales increase to $216.1 million. Key growth was driven by acquisitions and strong demand, with a record backlog of $295 million. Gross margin improved to 34.7%, while adjusted EPS rose 66.7% to $0.60. The company anticipates fourth quarter sales of approximately $235 million. CEO David Wilson highlighted the strategic benefit of recent acquisitions, especially in the food & beverage and pharmaceutical sectors.
- Sales increased 29.7% year-over-year to $216.1 million.
- Record backlog at $295 million.
- Gross margin improved to 34.7%; adjusted EPS rose 66.7% to $0.60.
- Fourth quarter sales expected to be approximately $235 million.
- None.
Third Quarter Highlights (compared with prior-year period)
- Advancing Columbus McKinnon’s transformation to intelligent motion solutions for material handling
- Garvey acquisition enhances precision conveyance platform with leading accumulation systems
-
Sales grew
30% from acquisitions, strong organic volume and improved pricing -
Orders up
14% year-over-year excluding acquisitions; strong demand across end markets; Backlog at quarter end was record$295 million -
Gross margin was
34.7% ; adjusted gross margin of36.7% matched record set in second quarter - Solid cash generation while building inventory to address strong demand amidst supply chain constraints
He added, “As a global expert in floor-to-ceiling intelligent motion solutions for material handling, we see our solutions as uniquely positioned to drive value in this global economy. Our solutions are enabling our customers in e-commerce, food & beverage, life sciences, aerospace and automotive to address some of the most pressing issues that they are facing today. We are providing critical support for vaccine deliveries, e-commerce expansion, supply chain rebalancing, labor shortages, capacity expansion and modernization.”
Third Quarter Fiscal 2022 Sales
($ in millions) |
Q3 FY 22 |
|
Q3 FY 21 |
|
Change |
|
% Change |
||||||||
Net sales |
$ |
216.1 |
|
|
$ |
166.5 |
|
|
$ |
49.5 |
|
|
29.7 |
% |
|
|
$ |
128.7 |
|
|
$ |
87.6 |
|
|
$ |
41.1 |
|
|
46.9 |
% |
|
% of total |
60 |
% |
|
53 |
% |
|
|
|
|
||||||
Non- |
$ |
87.4 |
|
|
$ |
78.9 |
|
|
$ |
8.5 |
|
|
10.8 |
% |
|
% of total |
40 |
% |
|
47 |
% |
|
|
|
|
For the quarter, sales increased
Third Quarter Fiscal 2022 Operating Results
($ in millions) |
Q3 FY 22 |
|
Q3 FY 21 |
|
Change |
|
% Change |
|||||||
Gross profit |
$ |
75.1 |
|
|
$ |
55.3 |
|
|
$ |
19.7 |
|
|
|
|
Gross margin |
34.7 |
% |
|
33.2 |
% |
|
150 bps |
|
|
|||||
Income from operations |
$ |
15.3 |
|
|
$ |
10.4 |
|
|
$ |
4.9 |
|
|
|
|
Operating margin |
7.1 |
% |
|
6.3 |
% |
|
80 bps |
|
|
|||||
Adjusted income from operations* |
$ |
20.5 |
|
|
$ |
11.2 |
|
|
$ |
9.3 |
|
|
|
|
Adjusted operating margin* |
9.5 |
% |
|
6.7 |
% |
|
280 bps |
|
|
|||||
Net income (loss) |
$ |
9.9 |
|
|
$ |
6.6 |
|
|
$ |
3.3 |
|
|
|
|
Net income (loss) margin |
4.6 |
% |
|
4.0 |
% |
|
60 bps |
|
|
|||||
Diluted EPS |
$ |
0.34 |
|
|
$ |
0.27 |
|
|
$ |
0.07 |
|
|
|
|
Adjusted EPS* |
$ |
0.60 |
|
|
$ |
0.36 |
|
|
$ |
0.24 |
|
|
|
|
Adjusted EBITDA* |
$ |
30.7 |
|
|
$ |
18.1 |
|
|
$ |
12.6 |
|
|
|
|
Adjusted EBITDA margin* |
14.2 |
% |
|
10.9 |
% |
|
330 bps |
|
|
*Adjusted operating income, adjusted operating margin, adjusted EPS, adjusted EBITDA, and adjusted EBITDA margin are non-GAAP measures. See accompanying discussion and reconciliation tables in this release regarding adjusted operating income, adjusted operating margin, adjusted EPS, and the reconciliation of GAAP net income (loss) to adjusted EBITDA.
Acquisitions added
Fourth Quarter Fiscal 2022 Outlook
Teleconference/webcast
The conference call can be accessed by dialing 201-493-6780. The listen-only audio webcast can be monitored at investors.columbusmckinnon.com. To listen to the archived call, dial 412-317-6671 and enter the passcode 13725924. The telephonic replay will be available from
About
Safe Harbor Statement
This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements concerning future sales and earnings, involve known and unknown risks, uncertainties and other factors that could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including the impact of supply chain challenges and inflation, the ability of the Company to scale the organization, achieve its Blueprint for Growth 2.0 strategy and execute CMBS; and the Company’s ability to achieve revenue expectations, global economic and business conditions, conditions affecting the industries served by the Company and its subsidiaries, the Company's customers and suppliers, competitor responses to the Company's products and services, the overall market acceptance of such products and services, the ability to expand into new markets and geographic regions, and other factors disclosed in the Company's periodic reports filed with the
Financial tables follow.
Condensed Consolidated Income Statements - UNAUDITED (In thousands, except per share and percentage data) |
||||||||||
|
|
Three Months Ended |
|
|
||||||
|
|
|
|
|
|
Change |
||||
Net sales |
|
$ |
216,088 |
|
|
$ |
166,547 |
|
|
|
Cost of products sold |
|
141,031 |
|
|
111,232 |
|
|
|
||
Gross profit |
|
75,057 |
|
|
55,315 |
|
|
|
||
Gross profit margin |
|
34.7 |
% |
|
33.2 |
% |
|
|
||
Selling expenses |
|
24,468 |
|
|
18,829 |
|
|
|
||
% of net sales |
|
11.3 |
% |
|
11.3 |
% |
|
|
||
General and administrative expenses |
|
25,144 |
|
|
19,859 |
|
|
|
||
% of net sales |
|
11.6 |
% |
|
11.9 |
% |
|
|
||
Research and development expenses |
|
3,875 |
|
|
3,038 |
|
|
|
||
% of net sales |
|
1.8 |
% |
|
1.8 |
% |
|
|
||
Amortization of intangibles |
|
6,254 |
|
|
3,142 |
|
|
|
||
Income from operations |
|
15,316 |
|
|
10,447 |
|
|
|
||
Operating margin |
|
7.1 |
% |
|
6.3 |
% |
|
|
||
Interest and debt expense |
|
4,375 |
|
|
2,986 |
|
|
|
||
Investment (income) loss |
|
(76) |
|
|
(495) |
|
|
(84.6)% |
||
Foreign currency exchange (gain) loss |
|
512 |
|
|
602 |
|
|
(15.0)% |
||
Other (income) expense, net |
|
(455) |
|
|
144 |
|
|
NM |
||
Income (loss) before income tax expense (benefit) |
|
10,960 |
|
|
7,210 |
|
|
|
||
Income tax expense (benefit) |
|
1,066 |
|
|
616 |
|
|
|
||
Net income (loss) |
|
$ |
9,894 |
|
|
$ |
6,594 |
|
|
|
|
|
|
|
|
|
|
||||
Average basic shares outstanding |
|
28,469 |
|
|
23,928 |
|
|
|
||
Basic income (loss) per share |
|
$ |
0.35 |
|
|
$ |
0.28 |
|
|
|
|
|
|
|
|
|
|
||||
Average diluted shares outstanding |
|
28,840 |
|
|
24,201 |
|
|
|
||
Diluted income (loss) per share |
|
$ |
0.34 |
|
|
$ |
0.27 |
|
|
|
|
|
|
|
|
|
|
||||
Dividends declared per common share |
|
$ |
0.06 |
|
|
$ |
0.06 |
|
|
|
Condensed Consolidated Income Statements - UNAUDITED (In thousands, except per share and percentage data) |
||||||||||
|
|
Nine Months Ended |
|
|
||||||
|
|
|
|
|
|
Change |
||||
Net sales |
|
$ |
653,187 |
|
|
$ |
463,407 |
|
|
|
Cost of products sold |
|
422,932 |
|
|
307,270 |
|
|
|
||
Gross profit |
|
230,255 |
|
|
156,137 |
|
|
|
||
Gross profit margin |
|
35.3 |
% |
|
33.7 |
% |
|
|
||
Selling expenses |
|
72,107 |
|
|
56,087 |
|
|
|
||
% of net sales |
|
11.0 |
% |
|
12.1 |
% |
|
|
||
General and administrative expenses |
|
78,495 |
|
|
53,842 |
|
|
|
||
% of net sales |
|
12.0 |
% |
|
11.6 |
% |
|
|
||
Research and development expenses |
|
11,283 |
|
|
8,703 |
|
|
|
||
% of net sales |
|
1.7 |
% |
|
1.9 |
% |
|
|
||
Amortization of intangibles |
|
18,648 |
|
|
9,449 |
|
|
|
||
Income from operations |
|
49,722 |
|
|
28,056 |
|
|
|
||
Operating margin |
|
7.6 |
% |
|
6.1 |
% |
|
|
||
Interest and debt expense |
|
14,774 |
|
|
9,192 |
|
|
|
||
Cost of debt refinancing |
|
14,803 |
|
|
— |
|
|
NM |
||
Investment (income) loss |
|
(624) |
|
|
(1,429) |
|
|
(56.3)% |
||
Foreign currency exchange (gain) loss |
|
1,047 |
|
|
1,083 |
|
|
(3.3)% |
||
Other (income) expense, net |
|
(744) |
|
|
20,081 |
|
|
NM |
||
Income (loss) before income tax expense (benefit) |
|
20,466 |
|
|
(871) |
|
|
NM |
||
Income tax expense (benefit) |
|
2,632 |
|
|
(392) |
|
|
NM |
||
Net income (loss) |
|
$ |
17,834 |
|
|
$ |
(479) |
|
|
NM |
|
|
|
|
|
|
|
||||
Average basic shares outstanding |
|
27,887 |
|
|
23,871 |
|
|
|
||
Basic income (loss) per share |
|
$ |
0.64 |
|
|
$ |
(0.02) |
|
|
NM |
|
|
|
|
|
|
|
||||
Average diluted shares outstanding |
|
28,255 |
|
|
23,871 |
|
|
|
||
Diluted income (loss) per share |
|
$ |
0.63 |
|
|
$ |
(0.02) |
|
|
NM |
|
|
|
|
|
|
|
||||
Dividends declared per common share |
|
$ |
0.12 |
|
|
$ |
0.12 |
|
|
|
Condensed Consolidated Balance Sheets (In thousands) |
||||||||
|
|
|
|
|
||||
|
|
(unaudited) |
|
|
||||
ASSETS |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
106,699 |
|
|
$ |
202,127 |
|
Trade accounts receivable |
|
125,879 |
|
|
105,464 |
|
||
Inventories |
|
175,099 |
|
|
111,488 |
|
||
Prepaid expenses and other |
|
33,449 |
|
|
22,763 |
|
||
Total current assets |
|
441,126 |
|
|
441,842 |
|
||
|
|
|
|
|
||||
Property, plant, and equipment, net |
|
98,219 |
|
|
74,753 |
|
||
|
|
657,084 |
|
|
331,176 |
|
||
Other intangibles, net |
|
400,560 |
|
|
213,362 |
|
||
Marketable securities |
|
11,099 |
|
|
7,968 |
|
||
Deferred taxes on income |
|
2,138 |
|
|
20,080 |
|
||
Other assets |
|
61,247 |
|
|
61,251 |
|
||
Total assets |
|
$ |
1,671,473 |
|
|
$ |
1,150,432 |
|
|
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Trade accounts payable |
|
$ |
74,061 |
|
|
$ |
68,593 |
|
Accrued liabilities |
|
116,410 |
|
|
110,816 |
|
||
Current portion of long-term debt and finance lease obligations |
|
40,530 |
|
|
4,450 |
|
||
Total current liabilities |
|
231,001 |
|
|
183,859 |
|
||
|
|
|
|
|
||||
Term loan and finance lease obligations |
|
480,589 |
|
|
244,504 |
|
||
Other non-current liabilities |
|
214,248 |
|
|
191,920 |
|
||
Total liabilities |
|
925,838 |
|
|
620,283 |
|
||
|
|
|
|
|
||||
Shareholders’ equity: |
|
|
|
|
||||
Common stock |
|
285 |
|
|
240 |
|
||
Additional paid-in capital |
|
503,701 |
|
|
296,093 |
|
||
Retained earnings |
|
308,223 |
|
|
293,802 |
|
||
Accumulated other comprehensive loss |
|
(66,574) |
|
|
(59,986) |
|
||
Total shareholders’ equity |
|
745,635 |
|
|
530,149 |
|
||
Total liabilities and shareholders’ equity |
|
$ |
1,671,473 |
|
|
$ |
1,150,432 |
|
Condensed Consolidated Statements of Cash Flows - UNAUDITED (In thousands) |
||||||||
|
|
Nine Months Ended |
||||||
|
|
|
|
|
||||
Operating activities: |
|
|
|
|
||||
Net income (loss) |
|
$ |
17,834 |
|
|
$ |
(479) |
|
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
31,245 |
|
|
21,203 |
|
||
Deferred income taxes and related valuation allowance |
|
(1,940) |
|
|
(7,344) |
|
||
Net loss (gain) on sale of real estate, investments, and other |
|
(390) |
|
|
(1,262) |
|
||
Stock based compensation |
|
8,485 |
|
|
5,840 |
|
||
Amortization of deferred financing costs |
|
1,274 |
|
|
1,986 |
|
||
Cost of debt refinancing |
|
14,803 |
|
|
— |
|
||
Loss (gain) on hedging instruments |
|
682 |
|
|
— |
|
||
Non-cash pension settlement expense |
|
— |
|
|
18,933 |
|
||
Gain on sale of building |
|
(375) |
|
|
(2,638) |
|
||
Non-cash lease expense |
|
5,936 |
|
|
5,721 |
|
||
Changes in operating assets and liabilities, net of effects of business acquisitions: |
|
|
|
|
||||
Trade accounts receivable |
|
3,931 |
|
|
34,254 |
|
||
Inventories |
|
(42,215) |
|
|
20,786 |
|
||
Prepaid expenses and other |
|
(5,544) |
|
|
(1,564) |
|
||
Other assets |
|
(298) |
|
|
545 |
|
||
Trade accounts payable |
|
(4,229) |
|
|
(8,764) |
|
||
Accrued liabilities |
|
2,608 |
|
|
(9,922) |
|
||
Non-current liabilities |
|
(8,080) |
|
|
(5,347) |
|
||
Net cash provided by (used for) operating activities |
|
23,727 |
|
|
71,948 |
|
||
|
|
|
|
|
||||
Investing activities: |
|
|
|
|
||||
Proceeds from sales of marketable securities |
|
3,441 |
|
|
4,231 |
|
||
Purchases of marketable securities |
|
(6,357) |
|
|
(4,067) |
|
||
Capital expenditures |
|
(9,506) |
|
|
(5,904) |
|
||
Proceeds from sale of building, net of transaction costs |
|
461 |
|
|
5,453 |
|
||
Proceeds from insurance reimbursement |
|
482 |
|
|
100 |
|
||
Purchases of businesses, net of cash acquired |
|
(539,778) |
|
|
— |
|
||
Dividend received from equity method investment |
|
324 |
|
|
587 |
|
||
Proceeds from sale of fixed assets |
|
— |
|
|
446 |
|
||
Net cash provided by (used for) investing activities |
|
(550,933) |
|
|
846 |
|
||
|
|
|
|
|
||||
Financing activities: |
|
|
|
|
||||
Proceeds from issuance of common stock |
|
2,520 |
|
|
1,828 |
|
||
Borrowings under line-of-credit agreements |
|
— |
|
|
25,000 |
|
||
Payments under line-of-credit agreements |
|
— |
|
|
(25,000) |
|
||
Repayment of debt |
|
(467,725) |
|
|
(3,338) |
|
||
Proceeds from issuance of long-term debt |
|
725,000 |
|
|
— |
|
||
Proceeds from equity offering |
|
207,000 |
|
|
— |
|
||
Fees related to debt and equity offering |
|
(26,184) |
|
|
— |
|
||
Cash inflows from hedging activities |
|
13,234 |
|
|
— |
|
||
Cash outflows from hedging activities |
|
(13,687) |
|
|
— |
|
||
Fees paid for revolver extension |
|
— |
|
|
(826) |
|
||
Payment of dividends |
|
(4,852) |
|
|
(4,294) |
|
||
Other |
|
(2,054) |
|
|
(1,050) |
|
||
Net cash provided by (used for) financing activities |
|
433,252 |
|
|
(7,680) |
|
||
|
|
|
|
|
||||
Effect of exchange rate changes on cash |
|
(1,474) |
|
|
8,062 |
|
||
|
|
|
|
|
||||
Net change in cash and cash equivalents |
|
(95,428) |
|
|
73,176 |
|
||
Cash, cash equivalents, and restricted cash at beginning of year |
|
202,377 |
|
|
114,700 |
|
||
Cash, cash equivalents, and restricted cash at end of period |
|
$ |
106,949 |
|
|
$ |
187,876 |
|
Q3 FY 2022 |
||||||||||||
|
|
Quarter |
|
Year To Date |
||||||||
($ in millions) |
|
$ Change |
|
% Change |
|
$ Change |
|
% Change |
||||
Fiscal 2021 Sales |
|
$ |
166.5 |
|
|
|
|
$ |
463.4 |
|
|
|
Acquisitions |
|
36.4 |
|
|
|
|
104.1 |
|
|
|
||
Volume |
|
9.1 |
|
|
|
|
66.7 |
|
|
|
||
Pricing |
|
5.6 |
|
|
|
|
11.6 |
|
|
|
||
Foreign currency translation |
|
(1.5) |
|
|
(0.9)% |
|
7.4 |
|
|
|
||
Total change |
|
$ |
49.6 |
|
|
|
|
$ |
189.8 |
|
|
|
Fiscal 2022 Sales |
|
$ |
216.1 |
|
|
|
|
$ |
653.2 |
|
|
|
Q3 FY 2022 |
|||||||
($ in millions) |
Quarter |
|
Year To Date |
||||
Fiscal 2021 Gross Profit |
$ |
55.3 |
|
|
$ |
156.1 |
|
Acquisitions |
16.7 |
|
|
44.0 |
|
||
Sales volume and mix |
3.2 |
|
|
23.1 |
|
||
Productivity, net of other cost changes |
3.6 |
|
|
11.9 |
|
||
Price, net of material cost inflation |
1.4 |
|
|
3.0 |
|
||
Prior year factory closure costs |
0.3 |
|
|
2.7 |
|
||
Foreign currency translation |
(0.5) |
|
|
2.4 |
|
||
Prior year business realignment costs |
0.2 |
|
|
0.6 |
|
||
Acquisition integration costs |
— |
|
|
(0.5) |
|
||
Acquisition amortization of backlog |
(0.5) |
|
|
(0.5) |
|
||
Business realignment costs |
(0.7) |
|
|
(1.6) |
|
||
Prior year gain on sale of building |
— |
|
|
(2.2) |
|
||
Tariffs |
(0.4) |
|
|
(2.2) |
|
||
Product liability |
(3.0) |
|
|
(3.0) |
|
||
Acquisition inventory step-up expense |
(0.5) |
|
|
(3.5) |
|
||
Total change |
19.8 |
|
|
74.2 |
|
||
Fiscal 2022 Gross Profit |
$ |
75.1 |
|
|
$ |
230.3 |
|
|
||||||||||
|
|
Q1 |
|
Q2 |
|
Q3 |
|
Q4 |
|
Total |
FY 22 |
|
63 |
|
64 |
|
61 |
|
63 |
|
251 |
|
|
|
|
|
|
|
|
|
|
|
FY 21 |
|
63 |
|
64 |
|
61 |
|
63 |
|
251 |
Additional Data - UNAUDITED |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
($ in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Backlog |
|
$ |
294.7 |
|
|
|
$ |
255.6 |
|
|
|
$ |
171.7 |
|
|
|
$ |
152.4 |
|
|
Long-term backlog |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Expected to ship beyond 3 months |
|
$ |
116.3 |
|
|
|
$ |
110.5 |
|
|
|
$ |
68.0 |
|
|
|
$ |
62.1 |
|
|
Long-term backlog as % of total backlog |
|
39.5 |
|
% |
|
43.2 |
|
% |
|
39.6 |
|
% |
|
40.7 |
|
% |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Trade accounts receivable |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Days sales outstanding (3) |
|
50.6 |
|
days |
|
51.0 |
|
days |
|
51.5 |
|
days |
|
51.5 |
|
days |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Inventory turns per year (3) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
(based on cost of products sold) |
|
3.3 |
|
turns |
|
3.9 |
|
turns |
|
4.4 |
|
turns |
|
3.9 |
|
turns |
||||
Days' inventory (3) |
|
111.4 |
|
days |
|
94.7 |
|
days |
|
83.3 |
|
days |
|
93.1 |
|
days |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Trade accounts payable |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Days payables outstanding (3) |
|
56.9 |
|
days |
|
54.3 |
|
days |
|
58.7 |
|
days |
|
46.6 |
|
days |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Working capital as a % of sales (2) |
|
15.2 |
|
% |
|
14.4 |
|
% |
|
9.3 |
|
% |
|
13.3 |
|
% |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net cash provided by (used for) operating activities |
|
$ |
5.8 |
|
|
|
$ |
25.3 |
|
|
|
$ |
26.9 |
|
|
|
$ |
25.0 |
|
|
Capital expenditures |
|
$ |
(2.8) |
|
|
|
$ |
3.1 |
|
|
|
$ |
6.4 |
|
|
|
$ |
3.1 |
|
|
Free cash flow (1) |
|
$ |
3.0 |
|
|
|
$ |
22.2 |
|
|
|
$ |
20.5 |
|
|
|
$ |
21.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Debt to total capitalization percentage |
|
41.1 |
|
% |
|
38.1 |
|
% |
|
32.0 |
|
% |
|
33.4 |
|
% |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Debt, net of cash, to net total capitalization |
|
35.7 |
|
% |
|
32.1 |
|
% |
|
8.1 |
|
% |
|
11.1 |
|
% |
(1) Free cash flow is defined as cash from operations less capital expenditures. Free cash flow is not a measure determined in accordance with generally accepted accounting principles in
Components may not add due to rounding.
(2)
(3)
Reconciliation of GAAP Gross Profit to Non-GAAP Adjusted Gross Profit ($ in thousands, except per share data) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
GAAP gross profit |
$ |
75,057 |
|
|
$ |
55,315 |
|
|
$ |
230,255 |
|
|
$ |
156,137 |
|
Add back (deduct): |
|
|
|
|
|
|
|
||||||||
Acquisition inventory step-up expense |
515 |
|
|
— |
|
|
3,496 |
|
|
— |
|
||||
Product liability settlement |
2,850 |
|
|
— |
|
|
2,850 |
|
|
— |
|
||||
Business realignment costs |
692 |
|
|
237 |
|
|
1,606 |
|
|
566 |
|
||||
Acquisition integration costs |
— |
|
|
— |
|
|
521 |
|
|
— |
|
||||
Acquisition amortization of backlog |
450 |
|
|
— |
|
|
450 |
|
|
— |
|
||||
Factory closures |
— |
|
|
250 |
|
|
— |
|
|
2,671 |
|
||||
Gain on sale of building |
— |
|
|
— |
|
|
— |
|
|
(2,189) |
|
||||
Non-GAAP adjusted gross profit |
$ |
79,564 |
|
|
$ |
55,802 |
|
|
$ |
239,178 |
|
|
$ |
157,185 |
|
|
|
|
|
|
|
|
|
||||||||
Sales |
$ |
216,088 |
|
|
$ |
166,547 |
|
|
$ |
653,187 |
|
|
$ |
463,407 |
|
Add back: |
|
|
|
|
|
|
|
||||||||
Acquisition amortization of backlog |
450 |
|
|
— |
|
|
450 |
|
|
— |
|
||||
Non-GAAP sales |
$ |
216,538 |
|
|
$ |
166,547 |
|
|
$ |
653,637 |
|
|
$ |
463,407 |
|
|
|
|
|
|
|
|
|
||||||||
Gross margin - GAAP |
34.7 |
% |
|
33.2 |
% |
|
35.3 |
% |
|
33.7 |
% |
||||
Adjusted gross margin - Non-GAAP |
36.7 |
% |
|
33.5 |
% |
|
36.6 |
% |
|
33.9 |
% |
Adjusted gross profit is defined as gross profit as reported, adjusted for certain items. Adjusted gross profit is not a measure determined in accordance with generally accepted accounting principles in
Reconciliation of GAAP Income from Operations to Non-GAAP Adjusted Income from Operations ($ in thousands, except per share data) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
GAAP income from operations |
$ |
15,316 |
|
|
$ |
10,447 |
|
|
$ |
49,722 |
|
|
$ |
28,056 |
|
Add back (deduct): |
|
|
|
|
|
|
|
||||||||
Acquisition deal and integration costs |
370 |
|
|
— |
|
|
10,244 |
|
|
— |
|
||||
Acquisition inventory step-up expense |
515 |
|
|
— |
|
|
3,496 |
|
|
— |
|
||||
Product liability settlement |
2,850 |
|
|
— |
|
|
2,850 |
|
|
— |
|
||||
Business realignment costs |
964 |
|
|
237 |
|
|
2,787 |
|
|
1,058 |
|
||||
Acquisition amortization of backlog |
450 |
|
|
— |
|
|
450 |
|
|
— |
|
||||
Factory closures |
— |
|
|
469 |
|
|
— |
|
|
3,472 |
|
||||
Insurance recovery legal costs |
— |
|
|
— |
|
|
— |
|
|
229 |
|
||||
Gain on sale of building |
— |
|
|
— |
|
|
— |
|
|
(2,638) |
|
||||
Non-GAAP adjusted income from operations |
$ |
20,465 |
|
|
$ |
11,153 |
|
|
$ |
69,549 |
|
|
$ |
30,177 |
|
|
|
|
|
|
|
|
|
||||||||
Sales |
$ |
216,088 |
|
|
$ |
166,547 |
|
|
$ |
653,187 |
|
|
$ |
463,407 |
|
Add back: |
|
|
|
|
|
|
|
||||||||
Acquisition amortization of backlog |
450 |
|
|
— |
|
|
450 |
|
|
— |
|
||||
Non-GAAP sales |
$ |
216,538 |
|
|
$ |
166,547 |
|
|
$ |
653,637 |
|
|
$ |
463,407 |
|
|
|
|
|
|
|
|
|
||||||||
Operating margin - GAAP |
7.1 |
% |
|
6.3 |
% |
|
7.6 |
% |
|
6.1 |
% |
||||
Adjusted operating margin - Non-GAAP |
9.5 |
% |
|
6.7 |
% |
|
10.6 |
% |
|
6.5 |
% |
Adjusted income from operations is defined as income from operations as reported, adjusted for certain items. Adjusted income from operations is not a measure determined in accordance with generally accepted accounting principles in
Reconciliation of GAAP Net Income and Diluted Earnings per Share to Non-GAAP Adjusted Net Income and Diluted Earnings per Share ($ in thousands, except per share data) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
GAAP net income (loss) |
$ |
9,894 |
|
|
$ |
6,594 |
|
|
$ |
17,834 |
|
|
$ |
(479) |
|
Add back (deduct): |
|
|
|
|
|
|
|
||||||||
Amortization of intangibles |
6,254 |
|
|
3,142 |
|
|
18,648 |
|
|
9,449 |
|
||||
Cost of debt refinancing |
— |
|
|
— |
|
|
14,803 |
|
|
— |
|
||||
Acquisition deal and integration costs |
370 |
|
|
— |
|
|
10,244 |
|
|
— |
|
||||
Acquisition inventory step-up expense |
515 |
|
|
— |
|
|
3,496 |
|
|
— |
|
||||
Product liability settlement |
2,850 |
|
|
— |
|
|
2,850 |
|
|
— |
|
||||
Business realignment costs |
964 |
|
|
237 |
|
|
2,787 |
|
|
1,058 |
|
||||
Acquisition amortization of backlog |
450 |
|
|
— |
|
|
450 |
|
|
— |
|
||||
Non-cash pension settlement expense |
— |
|
|
— |
|
|
— |
|
|
19,046 |
|
||||
Factory closures |
— |
|
|
469 |
|
|
— |
|
|
3,472 |
|
||||
Insurance recovery legal costs |
— |
|
|
— |
|
|
— |
|
|
229 |
|
||||
Gain on sale of building |
— |
|
|
— |
|
|
— |
|
|
(2,638) |
|
||||
Normalize tax rate to |
(3,854) |
|
|
(1,817) |
|
|
(13,592) |
|
|
(6,936) |
|
||||
Non-GAAP adjusted net income |
$ |
17,443 |
|
|
$ |
8,625 |
|
|
$ |
57,520 |
|
|
$ |
23,201 |
|
|
|
|
|
|
|
|
|
||||||||
Average diluted shares outstanding |
28,840 |
|
|
24,201 |
|
|
28,255 |
|
|
24,088 |
|
||||
|
|
|
|
|
|
|
|
||||||||
Diluted income (loss) per share - GAAP |
$ |
0.34 |
|
|
$ |
0.27 |
|
|
$ |
0.63 |
|
|
$ |
(0.02) |
|
|
|
|
|
|
|
|
|
||||||||
Diluted income per share - Non-GAAP |
$ |
0.60 |
|
|
$ |
0.36 |
|
|
$ |
2.04 |
|
|
$ |
0.96 |
|
(1) Applies a normalized tax rate of
Adjusted net income and diluted EPS are defined as net income and diluted EPS as reported, adjusted for certain items, including amortization of intangible assets, and also adjusted for a normalized tax rate. Adjusted net income and diluted EPS are not measures determined in accordance with generally accepted accounting principles in
Reconciliation of GAAP Net Income to Non-GAAP Adjusted EBITDA ($ in thousands) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
GAAP net income (loss) |
$ |
9,894 |
|
|
$ |
6,594 |
|
|
$ |
17,834 |
|
|
$ |
(479) |
|
Add back (deduct): |
|
|
|
|
|
|
|
||||||||
Income tax expense (benefit) |
1,066 |
|
|
616 |
|
|
2,632 |
|
|
(392) |
|
||||
Interest and debt expense |
4,375 |
|
|
2,986 |
|
|
14,774 |
|
|
9,192 |
|
||||
Investment (income) loss |
(76) |
|
|
(495) |
|
|
(624) |
|
|
(1,429) |
|
||||
Foreign currency exchange (gain) loss |
512 |
|
|
602 |
|
|
1,047 |
|
|
1,083 |
|
||||
Other (income) expense, net |
(455) |
|
|
144 |
|
|
(744) |
|
|
20,081 |
|
||||
Depreciation and amortization expense |
10,276 |
|
|
6,993 |
|
|
31,245 |
|
|
21,203 |
|
||||
Cost of debt refinancing |
— |
|
|
— |
|
|
14,803 |
|
|
— |
|
||||
Acquisition deal and integration costs |
370 |
|
|
— |
|
|
10,244 |
|
|
— |
|
||||
Acquisition inventory step-up expense |
515 |
|
|
— |
|
|
3,496 |
|
|
— |
|
||||
Product liability settlement |
2,850 |
|
|
— |
|
|
2,850 |
|
|
— |
|
||||
Business realignment costs |
964 |
|
|
237 |
|
|
2,787 |
|
|
1,058 |
|
||||
Acquisition amortization of backlog |
450 |
|
|
— |
|
|
450 |
|
|
— |
|
||||
Factory closures |
— |
|
|
469 |
|
|
— |
|
|
3,472 |
|
||||
Insurance recovery legal costs |
— |
|
|
— |
|
|
— |
|
|
229 |
|
||||
Gain on sale of building |
— |
|
|
— |
|
|
— |
|
|
(2,638) |
|
||||
Non-GAAP adjusted EBITDA |
$ |
30,741 |
|
|
$ |
18,146 |
|
|
$ |
100,794 |
|
|
$ |
51,380 |
|
|
|
|
|
|
|
|
|
||||||||
Sales |
$ |
216,088 |
|
|
$ |
166,547 |
|
|
$ |
653,187 |
|
|
$ |
463,407 |
|
Add back: |
|
|
|
|
|
|
|
||||||||
Acquisition amortization of backlog |
450 |
|
|
— |
|
|
450 |
|
|
— |
|
||||
Non-GAAP sales |
$ |
216,538 |
|
|
$ |
166,547 |
|
|
$ |
653,637 |
|
|
$ |
463,407 |
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss) margin - GAAP |
4.6 |
% |
|
4.0 |
% |
|
2.7 |
% |
|
(0.1) |
% |
||||
Adjusted EBITDA margin - Non-GAAP |
14.2 |
% |
|
10.9 |
% |
|
15.4 |
% |
|
11.1 |
% |
Adjusted EBITDA is defined as net income before interest expense, income taxes, depreciation, amortization, and other adjustments. Adjusted EBITDA is not a measure determined in accordance with generally accepted accounting principles in
View source version on businesswire.com: https://www.businesswire.com/news/home/20220127005285/en/
Senior Vice President - Finance and Chief Financial Officer
716-689-5442
greg.rustowicz@cmworks.com
Investor Relations:
716-843-3908
dpawlowski@keiadvisors.com
Source:
FAQ
What were Columbus McKinnon's Q3 fiscal 2022 sales results?
How did acquisitions impact Columbus McKinnon's revenue?
What is Columbus McKinnon's expected sales for Q4 fiscal 2022?
What was the adjusted EPS for Columbus McKinnon in Q3 fiscal 2022?